Skip to content
Home - Investors - Financial results - 2005    
2005 Financial results
Fourth quarter & full year results 2005 (2 February 2006)
PDF Narrative - 76 kbopens in a new window
PDF Figures - 83 kbopens in a new window
PDF Pipeline table - 48 kbopens in a new window

Interviews
The following pre-recorded interviews are available in video, audio and text format
> David Brennan (Chief Executive Officer) opens in a new window
> Jon Symonds (Chief Financial Officer) opens in a new window
> John Patterson (Executive Director, Drug Development) opens in a new window

Presentation 
PDF Presentation - 305 kb opens in a new window

Presentation scripts
PDF David Brennan – Chief Executive Officer - 77 kbopens in a new window
PDF Jon Symonds – Chief Financial Officer - 81 kbopens in a new window
PDF John Patterson – Executive Director Development - 73 kb opens in a new window


Third quarter and nine months results 2005 (27 October 2005)
PDF Narrative - 63 kb opens in a new window
PDF Figures - 61 kbopens in a new window

Second quarter & half year results 2005 (28 July 2005)

PDF Narrative - 58 kbopens in a new window
PDF Figures - 90 kbopens in a new window
PDF Pipeline table - 54 kbopens in a new window
PDF Galaxy summary - 50 kbopens in a new window
PDF Renovis press release - 40 kbopens in a new window

Interviews
The following pre-recorded interviews are available in video, audio and text format
> Sir Tom McKillop (Chief Executive Officer)
 opens in a new window
> Jon Symonds (Chief Financial Officer)
 opens in a new window
> John Patterson (Executive Director, Drug Development)
 opens in a new window
> David Brennan (Executive Vice President, North America)
 opens in a new window

Presentation
PDF Second quarter and half year results presentation - 260 kbopens in a new window
Presented by:
Sir Tom McKillop (Chief Executive Officer)
David Brennan (Executive Vice President, North America)
Jon Symonds (Chief Financial Officer)
John Patterson (Executive Director, Drug Development)

Presentation Scripts
PDF Sir Tom McKillop (Chief Executive Officer) - opening script opens in a new window
PDF David Brennan (Executive Vice President, North America)opens in a new window
PDF Jon Symonds (Chief Financial Officer)opens in a new window
PDF John Patterson (Executive Vice President, Drug Development)opens in a new window
PDF Sir Tom McKillop (Chief Executive Officer) - closing scriptopens in a new window


First quarter results 2005 (28 April 2005)
PDF Narrative - 48 kbopens in a new window
PDF Figures - 39 kbopens in a new window
AstraZeneca websites
Search
Quick links
Share price
>
>
>